Philipines are the mostly likely to buy quickly, t
Post# of 148292
No reason to think that LL won't be efficacious against all variants/mutations.
Cytodyn is open to considering partnerships.
Meeting Primary Endpoint for trial with140 critical patients will be highly probable.
Days to be released from hospital.
Janet Woodcock, FDA Director should hopefully will issue an EUA now based on data.
Demand and future for leronlimab for covid-19 looks excellent regarding competition.